F23Fulvestrant (FUL) 500 milligrams as endocrine therapy...

Annals of Oncology 2016 / 09 Vol. 27; Iss. suppl_4

F23Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial

Moscetti, L., Fabbri, M.A., Vici, P., Natoli, C., Gamucci, T., Sperduti, I., Pizzuti, L., Iezzi, L., Iattoni, E., Roma, C.L., Vaccaro, A., D'Auria, G., Mauri, M., Ruggeri, E.M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw337.23
Date:
September, 2016
File:
PDF, 63 KB
2016
Conversion to is in progress
Conversion to is failed